仙灵骨葆胶囊联合髋关节置换术治疗老年股骨颈骨折合并骨质疏松的疗效分析
|
摘要
目的:探讨仙灵骨葆胶囊联合髋关节置换术治疗老年股骨颈骨折合并骨质疏松的疗效。方法:选取2016年1月至2018年1月广西北海市中医医院收治的老年股骨颈骨折合并骨质疏松患者82例,按随机数字表法分为对照组和观察组,每组41例。对照组采取全髋关节置换术,观察组在对照组治疗基础上于术后2d口服仙灵骨葆胶囊治疗,连续治疗6个月。比较两组股骨部骨密度、髋关节Harris评分、步行能力评分及下肢体运动功能(FMMS)评分。结果:术后6个月,观察组髋关节Harris评分、FMMS评分及股骨颈、大转子、Wards三角骨密度明显高于对照组,步行能力评分明显低于对照组,差异均有统计学意义(均P<0.01)。结论:仙灵骨葆胶囊联合髋关节置换术治疗老年股骨颈骨折合并骨质疏松的疗效显著,可明显提高患者的步行能力和骨密度,值得临床借鉴。
Objective:To investigate the efficacy of Xianling Gubao capsule combined with hip replacement in the treatment of femoral neck fractures combined with osteoporosis in elderly patients.Methods:Eighty-two elderly patients with femoral neck fractures combined with osteoporosis in our hospital from January 2016 to January 2018 were selected,and randomly divided into a control group and an observation group,with41 cases in each group.The patients in the control group received hip replacement arthroplasty,and those in the observation group were treated as the control group with addition of Xianling Gubao capsule.Femoral bone density,Harris score,walking function score and Fugl-Meyer assessment scale(FMMS)score were compared.Results:After six months of operation,Harris score,FMMS score,and Femoral neck,greater trochanter,Wards triangle bone density in the observation group were evidently higher than those in the control group,while the score of walking function was obviously lower(P<0.01).Conclusion:Xianling Gubao capsule combined with hip replacement had significant curative effect in the treatment of femoral neck fractures combined with osteoporosis.It could enhance walking ability and bone density of elderly patients.
Objective:To investigate the efficacy of Xianling Gubao capsule combined with hip replacement in the treatment of femoral neck fractures combined with osteoporosis in elderly patients.Methods:Eighty-two elderly patients with femoral neck fractures combined with osteoporosis in our hospital from January 2016 to January 2018 were selected,and randomly divided into a control group and an observation group,with41 cases in each group.The patients in the control group received hip replacement arthroplasty,and those in the observation group were treated as the control group with addition of Xianling Gubao capsule.Femoral bone density,Harris score,walking function score and Fugl-Meyer assessment scale(FMMS)score were compared.Results:After six months of operation,Harris score,FMMS score,and Femoral neck,greater trochanter,Wards triangle bone density in the observation group were evidently higher than those in the control group,while the score of walking function was obviously lower(P<0.01).Conclusion:Xianling Gubao capsule combined with hip replacement had significant curative effect in the treatment of femoral neck fractures combined with osteoporosis.It could enhance walking ability and bone density of elderly patients.
引文
[1]袁权华,黄福才,袁国伟.人工股骨头置换术对高龄髋部骨折合并骨质疏松患者的疗效影响[J].现代诊断与治疗,2015,26(24):5633-5635.
[2]吴鹏,王博,孔令成,等.强骨饮颗粒联合阿仑膦酸钠维D3片口服在原发性骨质疏松性髋部骨折术后抗骨质疏松治疗中的应用[J].中医正骨,2016,28(5):16-19.
[3]王福平,陈斌,史世勤.骨质疏松对非骨水泥型人工全髋关节置换术患者近远期疗效的影响[J].临床和实验医学杂志,2017,16(24):2457-2460.
[4]兰孝忠,周特.手术辅助药物治疗老年骨质疏松性髓部骨折效果的临床观察[J].中国医药指南,2014,12(4):144-145.
[5]赵建根,马超.PVP结合仙灵骨葆胶囊治疗老年性骨质疏松症伴骨折临床疗效评价[J].中华中医药学刊,2016,34(11):2805-2807.
[6]中国老年学学会骨质疏松委员会.中国人骨质疏松症诊断标准专家共识(第3稿)[J].中国骨质疏松杂志,2014,20(9):1007-1010.
[7]蒋协远,王大伟.骨科临床疗效评价标准[M].北京:人民卫生出版社,2007:37-38.
[8] HARRIS W H.Hybrid total hip replacement:rationale and intermediate clinical results[J].Clin Orthop Relat Res,1996(333):155-164.
[9]中华神经科学会,中华神经外科学会.脑卒中患者临床神经功能缺损程度评分标准[J].中华神经科杂志,1996,29(6):62-64.
[10]缪鸿石.康复医学理论与实践[M].上海:上海科学技术出版社,2000:336.
[11]丁修龙,张建华,李玉前,等.骨质疏松性髋部骨折患者心理状况与预后的相关性研究[J].海南医学,2018,29(1):50-52.
[12]张勋兵.髋关节置换术治疗骨质疏松性髋部骨折30例临床观察[J].中国民族民间医药,2015,24(21):59,61.
[13]徐万龙,缪晓刚,塔依尔江·举来提,等.维、汉民族差异对全髋关节置换术后绝经后骨质疏松妇女骨密度的影响[J].中国骨质疏松杂志,2012,18(6):539-541.
[14]李春雯.益气温经法对绝经后骨质疏松性髋部骨折患者骨转换指标的影响[J].中医正骨,2014,26(12):7-9.
[15]邱贵兴,裴福兴,胡侦明,等.中国骨质疏松性骨折诊疗指南(骨质疏松性骨折诊断及治疗原则)[J].中华骨与关节外科杂志,2015,5(5):371-374.
[16]王一强,史鹏亮,张玉香.仙灵骨葆胶囊治疗老年骨质疏松性胸腰椎压缩性骨折的临床观察[J].西部中医药,2015,28(11):96-98.
[17]张耿明,屈燕铭,蔡志辉,等.雷奈酸锶预防人工髋关节置换术后假体周围骨溶解的临床研究[J].中国医师进修杂志,2013,36(14):33-35.
[18]陈勍,刘钟,陈文亮,等.股骨近端防旋髓内钉固定联合口服仙灵骨葆胶囊治疗肾阳虚型骨质疏松性股骨转子间骨折[J].中医正骨,2017,29(7):69-73.
[2]吴鹏,王博,孔令成,等.强骨饮颗粒联合阿仑膦酸钠维D3片口服在原发性骨质疏松性髋部骨折术后抗骨质疏松治疗中的应用[J].中医正骨,2016,28(5):16-19.
[3]王福平,陈斌,史世勤.骨质疏松对非骨水泥型人工全髋关节置换术患者近远期疗效的影响[J].临床和实验医学杂志,2017,16(24):2457-2460.
[4]兰孝忠,周特.手术辅助药物治疗老年骨质疏松性髓部骨折效果的临床观察[J].中国医药指南,2014,12(4):144-145.
[5]赵建根,马超.PVP结合仙灵骨葆胶囊治疗老年性骨质疏松症伴骨折临床疗效评价[J].中华中医药学刊,2016,34(11):2805-2807.
[6]中国老年学学会骨质疏松委员会.中国人骨质疏松症诊断标准专家共识(第3稿)[J].中国骨质疏松杂志,2014,20(9):1007-1010.
[7]蒋协远,王大伟.骨科临床疗效评价标准[M].北京:人民卫生出版社,2007:37-38.
[8] HARRIS W H.Hybrid total hip replacement:rationale and intermediate clinical results[J].Clin Orthop Relat Res,1996(333):155-164.
[9]中华神经科学会,中华神经外科学会.脑卒中患者临床神经功能缺损程度评分标准[J].中华神经科杂志,1996,29(6):62-64.
[10]缪鸿石.康复医学理论与实践[M].上海:上海科学技术出版社,2000:336.
[11]丁修龙,张建华,李玉前,等.骨质疏松性髋部骨折患者心理状况与预后的相关性研究[J].海南医学,2018,29(1):50-52.
[12]张勋兵.髋关节置换术治疗骨质疏松性髋部骨折30例临床观察[J].中国民族民间医药,2015,24(21):59,61.
[13]徐万龙,缪晓刚,塔依尔江·举来提,等.维、汉民族差异对全髋关节置换术后绝经后骨质疏松妇女骨密度的影响[J].中国骨质疏松杂志,2012,18(6):539-541.
[14]李春雯.益气温经法对绝经后骨质疏松性髋部骨折患者骨转换指标的影响[J].中医正骨,2014,26(12):7-9.
[15]邱贵兴,裴福兴,胡侦明,等.中国骨质疏松性骨折诊疗指南(骨质疏松性骨折诊断及治疗原则)[J].中华骨与关节外科杂志,2015,5(5):371-374.
[16]王一强,史鹏亮,张玉香.仙灵骨葆胶囊治疗老年骨质疏松性胸腰椎压缩性骨折的临床观察[J].西部中医药,2015,28(11):96-98.
[17]张耿明,屈燕铭,蔡志辉,等.雷奈酸锶预防人工髋关节置换术后假体周围骨溶解的临床研究[J].中国医师进修杂志,2013,36(14):33-35.
[18]陈勍,刘钟,陈文亮,等.股骨近端防旋髓内钉固定联合口服仙灵骨葆胶囊治疗肾阳虚型骨质疏松性股骨转子间骨折[J].中医正骨,2017,29(7):69-73.